135 related articles for article (PubMed ID: 2457305)
1. Hemodynamic comparison of dopexamine hydrochloride and dopamine in ischemic left ventricular dysfunction.
Jackson NC; Taylor SH; Frais MA
Am J Cardiol; 1988 Aug; 62(5):73C-77C. PubMed ID: 2457305
[TBL] [Abstract][Full Text] [Related]
2. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
[TBL] [Abstract][Full Text] [Related]
3. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Jaski BE; Peters C
Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function.
Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG
J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193
[TBL] [Abstract][Full Text] [Related]
5. Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
Colardyn FA; Vandenbogaerde JF
Am J Cardiol; 1988 Aug; 62(5):68C-72C. PubMed ID: 3407598
[TBL] [Abstract][Full Text] [Related]
6. Dopexamine hydrochloride after coronary artery bypass grafting.
van der Starre PJ; Rosseel PM
Am J Cardiol; 1988 Aug; 62(5):78C-82C. PubMed ID: 3261535
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects.
Foulds RA
Am J Cardiol; 1988 Aug; 62(5):41C-45C. PubMed ID: 3044060
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
[TBL] [Abstract][Full Text] [Related]
9. [Dopexamine: a new dopaminergic agonist].
Perrin G; Papazian L; Martin C
Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
[TBL] [Abstract][Full Text] [Related]
10. Temporal effects of an infusion of dopexamine hydrochloride in horses anesthetized with halothane.
Young LE; Blissitt KJ; Clutton RE; Molony V
Am J Vet Res; 1997 May; 58(5):516-23. PubMed ID: 9140561
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting.
MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL
Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979
[TBL] [Abstract][Full Text] [Related]
12. Effect of dopexamine hydrochloride in the early stages of experimental myocardial infarction and comparison with dopamine and dobutamine.
Parratt JR; Wainwright CL; Fagbemi O
Am J Cardiol; 1988 Aug; 62(5):18C-23C. PubMed ID: 2457304
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
Gollub SB; Elkayam U; Young JB; Miller LW; Haffey KA
J Am Coll Cardiol; 1991 Aug; 18(2):383-90. PubMed ID: 1677368
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Baumann G; Felix SB; Filcek SA
Am J Cardiol; 1990 Mar; 65(11):748-54. PubMed ID: 1969223
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G
Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466
[TBL] [Abstract][Full Text] [Related]
16. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
Santman FW
J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
[TBL] [Abstract][Full Text] [Related]
18. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
Svenson G; Strandberg LE; Lindvall B; Erhardt L
Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
Gollub SB; Emmot WW; Johnson DE; Sights KA; Wilson DB; Vacek JL; Hassanein K
Am J Cardiol; 1988 Aug; 62(5):83C-88C. PubMed ID: 3407599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
